Literature DB >> 19276782

Migraine in metabolic syndrome.

Baburhan Guldiken1, Sibel Guldiken, Bengur Taskiran, Gonul Koc, Nilda Turgut, Levent Kabayel, Armagan Tugrul.   

Abstract

OBJECTIVES: Recent studies suggest that insulin resistance is more common in patients with migraine. Insulin resistance underlies the pathogenesis of obesity, diabetes, and hypertension that are components of metabolic syndrome. As migraine is associated with an increased risk of vascular disorders, such as stroke, and migraine patients have higher diastolic blood pressure than healthy individuals, we aimed to investigate the 1-year prevalence of migraine in metabolic syndrome.
METHODS: Two hundred ten patients with metabolic syndrome were enrolled in the study. Migraine was diagnosed according to International Classification of Headache Disorders-II criteria.
RESULTS: Migraine prevalence was estimated as 11.9% in men and 22.5% in women with metabolic syndrome. Of the metabolic syndrome components, diabetes, increased waist circumference, and body mass index were significantly more frequent in patients with migraine in contrast to those without migraine (P<0.05). Hypertension and dyslipidemia frequencies showed no difference between 2 groups.
CONCLUSIONS: Our results demonstrate that migraine prevalence in metabolic syndrome was higher than in the general population.

Entities:  

Mesh:

Year:  2009        PMID: 19276782     DOI: 10.1097/NRL.0b013e31817781b6

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  19 in total

Review 1.  Migraine and metabolism.

Authors:  G Casucci; V Villani; D Cologno; F D'Onofrio
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Metabolic syndrome and insulin resistance in migraine.

Authors:  Sanjeev K Bhoi; Jayantee Kalita; Usha K Misra
Journal:  J Headache Pain       Date:  2012-01-26       Impact factor: 7.277

3.  Non-alcoholic fatty liver disease in patients with migraine.

Authors:  Asuman Celikbilek; Mehmet Celikbilek; Aylin Okur; Serkan Dogan; Elif Borekci; Mustafa Kozan; Sebnem Gursoy
Journal:  Neurol Sci       Date:  2014-04-23       Impact factor: 3.307

Review 4.  Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment.

Authors:  D S Bond; J Roth; J M Nash; R R Wing
Journal:  Obes Rev       Date:  2011-05       Impact factor: 9.213

5.  Body mass index and adult weight gain among reproductive age women with migraine.

Authors:  Michelle Vo; Abinnet Ainalem; Chunfang Qiu; B Lee Peterlin; Sheena K Aurora; Michelle A Williams
Journal:  Headache       Date:  2011-01-26       Impact factor: 5.887

6.  Clinical Pain Catastrophizing in Women With Migraine and Obesity.

Authors:  Dale S Bond; Dawn C Buse; Richard B Lipton; J Graham Thomas; Lucille Rathier; Julie Roth; Jelena M Pavlovic; E Whitney Evans; Rena R Wing
Journal:  Headache       Date:  2015-06-18       Impact factor: 5.887

Review 7.  Is there any association between migraine headache and polycystic ovary syndrome (PCOS)? A review article.

Authors:  Nahid Sarahian; Mahsa Noroozzadeh; Marzieh Saei Ghare Naz; Narges Eskandari-Roozbahani; Fatemeh Mahboobifard; Fahimeh Ramezani Tehrani
Journal:  Mol Biol Rep       Date:  2021-10-15       Impact factor: 2.316

Review 8.  Is Migraine Primarily a Metaboloendocrine Disorder?

Authors:  Innocenzo Rainero; Flora Govone; Annalisa Gai; Alessandro Vacca; Elisa Rubino
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

9.  Secular Trends in the Incidence of Migraine in China from 1990 to 2019: A Joinpoint and Age-Period-Cohort Analysis.

Authors:  Yufeng Wang; Xueying Huang; Suru Yue; Jie Liu; Shasha Li; Huan Ma; Liren Hu; Jiayuan Wu
Journal:  J Pain Res       Date:  2022-01-14       Impact factor: 3.133

Review 10.  Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus.

Authors:  Eduardo Rivera-Mancilla; Linda Al-Hassany; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.